Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
esophageal diseases
MeSH D004935 - esophageal diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D005767:
Gastrointestinal diseases
32 Companies
12 Drugs
$
Success rate
D004935:
Esophageal diseases
80 Companies
15 Drugs
$
Success rate
D001471:
Barrett esophagus
1 Company
1 Drug
$
Success rate
D003680:
Deglutition disorders
0 Companies
0 Drugs
Success rate
D004932:
Esophageal and gastric varices
34 Companies
4 Drugs
$
Success rate
D004933:
Esophageal atresia
0 Companies
0 Drugs
Success rate
D004934:
Esophageal cyst
0 Companies
0 Drugs
Success rate
D004937:
Esophageal fistula
0 Companies
0 Drugs
Success rate
D004938:
Esophageal neoplasms
38 Companies
3 Drugs
$
Success rate
D004939:
Esophageal perforation
0 Companies
0 Drugs
Success rate
D004940:
Esophageal stenosis
0 Companies
0 Drugs
Success rate
D004941:
Esophagitis
85 Companies
11 Drugs
$
Success rate
D045723:
Esophageal diverticulosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/9
Phase 3
50
%
2/4
Approved:
2
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Ceftriaxone
,
Lidocaine
AstraZeneca
Lidocaine
,
Prilocaine
,
Epinephrine
,
Nktr118
Novartis
Dihydroergotamine
,
Heparin
,
Heparin sodium
,
Lidocaine
Sanofi
Dupilumab
Merck & Co
Dexamethasone
,
Lidocaine
Pfizer
Lidocaine
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use